IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

SERPENTE, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.350
AS - Asia 7.004
EU - Europa 6.710
Continente sconosciuto - Info sul continente non disponibili 851
SA - Sud America 642
AF - Africa 173
OC - Oceania 63
Totale 22.793
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.986
SG - Singapore 1.986
CN - Cina 1.901
GB - Regno Unito 1.748
IT - Italia 1.746
BD - Bangladesh 854
DE - Germania 725
VN - Vietnam 645
SE - Svezia 619
HK - Hong Kong 535
BR - Brasile 487
RU - Federazione Russa 460
IN - India 336
FR - Francia 333
CA - Canada 261
NL - Olanda 221
IE - Irlanda 191
TR - Turchia 164
KR - Corea 140
FI - Finlandia 135
JP - Giappone 125
ID - Indonesia 86
DK - Danimarca 85
PL - Polonia 83
CI - Costa d'Avorio 73
UA - Ucraina 69
ES - Italia 65
BE - Belgio 59
AU - Australia 56
AR - Argentina 43
CO - Colombia 41
IQ - Iraq 35
MX - Messico 35
GR - Grecia 33
ZA - Sudafrica 32
IR - Iran 28
AT - Austria 25
UZ - Uzbekistan 21
CH - Svizzera 19
EC - Ecuador 19
EU - Europa 18
TW - Taiwan 18
PK - Pakistan 16
MA - Marocco 13
PH - Filippine 13
RO - Romania 13
SA - Arabia Saudita 12
CR - Costa Rica 11
EG - Egitto 11
UY - Uruguay 11
VE - Venezuela 11
AE - Emirati Arabi Uniti 10
CL - Cile 10
CZ - Repubblica Ceca 10
HN - Honduras 10
PT - Portogallo 10
JM - Giamaica 9
JO - Giordania 9
MY - Malesia 9
NO - Norvegia 9
PE - Perù 9
NP - Nepal 8
PA - Panama 8
TN - Tunisia 8
BG - Bulgaria 7
IL - Israele 7
LT - Lituania 7
NZ - Nuova Zelanda 7
XK - ???statistics.table.value.countryCode.XK??? 7
AL - Albania 6
DZ - Algeria 6
GT - Guatemala 6
KE - Kenya 6
LB - Libano 6
PY - Paraguay 6
RS - Serbia 6
AZ - Azerbaigian 5
KZ - Kazakistan 5
SV - El Salvador 5
TH - Thailandia 5
DO - Repubblica Dominicana 4
EE - Estonia 4
HU - Ungheria 4
OM - Oman 4
SN - Senegal 4
TT - Trinidad e Tobago 4
AM - Armenia 3
BO - Bolivia 3
BY - Bielorussia 3
KG - Kirghizistan 3
LU - Lussemburgo 3
LV - Lettonia 3
PR - Porto Rico 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
AO - Angola 2
BF - Burkina Faso 2
BH - Bahrain 2
CW - ???statistics.table.value.countryCode.CW??? 2
ET - Etiopia 2
Totale 21.929
Salva come PNG Salva come JPEG
Città #
Southend 1.516
Singapore 1.185
Ashburn 857
Hong Kong 478
Milan 437
San Jose 413
Chandler 392
Council Bluffs 310
Beijing 275
New York 262
Seattle 255
Santa Clara 237
Dallas 220
Princeton 213
Wilmington 212
Los Angeles 211
Fairfield 205
Ho Chi Minh City 205
Dublin 186
Ann Arbor 177
Cambridge 169
Hanoi 152
Woodbridge 132
Buffalo 127
Frankfurt am Main 121
Houston 115
Nanjing 112
Berlin 109
Rome 109
Lauterbourg 106
Boardman 101
Guangzhou 96
Hefei 94
Bengaluru 93
Moscow 89
The Dalles 89
Toronto 80
Abidjan 73
Warsaw 68
Des Moines 67
Munich 66
Tokyo 66
Dearborn 65
Shanghai 64
Jakarta 63
Jinan 58
Kent 58
Naples 55
Phoenix 54
Shenyang 52
Ottawa 51
Columbus 50
Cangzhou 49
Redwood City 47
Helsinki 46
São Paulo 45
Redmond 43
Tianjin 43
Brussels 41
Mountain View 40
Chicago 39
Turin 39
London 36
Nuremberg 34
Changsha 33
Hangzhou 33
Seoul 33
Da Nang 31
Bogotá 30
Istanbul 30
Norwalk 30
Bologna 29
Bühl 29
Nanchang 28
Montreal 27
Andover 26
Sakarya 25
Shenzhen 25
Amsterdam 24
Dong Ket 24
Atlanta 23
Haiphong 21
Athens 19
Cagliari 19
Wuhan 19
Zhengzhou 19
Brescia 18
Johannesburg 18
Washington 18
Central District 17
Chengdu 17
Fuzhou 17
Orem 17
Catania 16
Denver 16
Düsseldorf 16
Eitensheim 16
Genoa 16
Jiaxing 16
Palermo 16
Totale 12.363
Salva come PNG Salva come JPEG
Nome #
MALATTIA DI ALZHEIMER E DEGENERAZIONE LOBARE FRONTOTEMPORALE: RICERCA DI MUTAZIONI AUTOSOMICHE DOMINANTI E ANALISI GENETICA E FUNZIONALE DI GENI CANDIDATI 724
Phenotypic variability associated with the C9ORF72 hexanucleotide repeat expansion : a sporadic case of frontotemporal lobar degeneration with prodromal hyposmia and predominant semantic deficits 421
Frontotemporal dementia and its subtypes: a genome-wide association study 356
The novel GRN g.1159-1160delTG mutation is associated with behavioral variant frontotemporal dementia 352
Progranulin gene variability and plasma levels in bipolar disorder and schizophrenia 315
Evidence of pre-synaptic dopaminergic deficit in a patient with a novel progranulin mutation presenting with atypical parkinsonism 298
Role of hnRNP-A1 and miR-590-3p in neuronal death : genetics and expression analysis in patients with Alzheimer’s disease and frontotemporal lobar degeneration 295
MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease 294
Incomplete penetrance of the C9ORF72 hexanucleotide repeat expansions : Frequency in a cohort of geriatric non-demented subjects 272
Exosome determinants of physiological aging and age-related neurodegenerative diseases 269
Late-onset presentation and phenotypic heterogeneity of the rare R377W PSEN1 mutation 268
GRN variability contributes to sporadic frontotemporal lobar degeneration 267
Causal frontotemporal de generation mutations : a novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 259
BAG1 is a protective factor for sporadic frontotemporal lobar degeneration but not for Alzheimer's disease 258
Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer’s disease : genetics and expression analysis 257
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 257
Genetics and expression analysis of the specificity protein 4 gene (SP4) in patients with Alzheimer's disease and frontotemporal lobar degeneration 249
Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease? 248
Association between enlarged perivascular spaces and cerebrospinal fluid aquaporin-4 and tau levels: report from a memory clinic 247
Profiling of ubiquitination pathway genes in peripheral cells from patients with frontotemporal dementia due to C9ORF72 and GRN mutations 244
Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort 242
Altered Extracellular Vesicle miRNA Profile in Prodromal Alzheimer's Disease 241
Cell-dependent kinase inhibitor 2A and 2B genetic variability in patients with Alzheimer's disease 241
Candidate gene analysis of semaphorins in patients with Alzheimer's disease 239
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 239
Plasma microglial-derived extracellular vesicles are increased in frail patients with Mild Cognitive Impairment and exert a neurotoxic effect 236
Circulating miRNAs as potential biomarkers in Alzheimer's disease 236
Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study 236
Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis 233
Role of hnRNP-A1 and miR-590-3p in Neuronal Death : Genetics and Expression Analysis in Patients with Alzheimer Disease and Frontotemporal Lobar Degeneration 231
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis : correlation with CSF β-amyloid levels and brain volumes 231
C9orf72, AAO and ancestry help discriminating behavioural from language variants in FTLD cohorts 227
Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer's Disease and Frontotemporal Dementia 224
Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred 223
Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion : late-onset psychotic clinical presentation 223
miR-150-5p and let-7b-5p in Blood Myeloid Extracellular Vesicles Track Cognitive Symptoms in Patients with Multiple Sclerosis 221
Role of OLR1 and its regulating hsa-miR369-3p in Alzheimer’s disease : genetic and expression analysis 218
Causal frontotemporal lobar degeneration mutations : a novel mutation in MAPT associated with non-fluent Progressive Aphasia phenotype 216
Progranulin gene variability influences the risk for bipolar I disorder, but not bipolar II disorder 216
A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease 215
Monozygotic Twins with Frontotemporal Dementia Due to Thr272fs GRN Mutation Discordant for Age at Onset 209
Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation 208
CXCR4 involvement in neurodegenerative diseases 205
GSK3β genetic variability in patients with Multiple Sclerosis 204
C9ORF72 repeat expansion not detected in patients with multiple sclerosis 204
PRNP P39L variant is a rare cause of frontotemporal dementia in Italian population 204
A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors 203
Inflammatory molecules in Frontotemporal Dementia : Cerebrospinal fluid signature of progranulin mutation carriers 203
Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with alzheimer's disease 202
Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia 200
Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred 200
A “glympse” into neurodegeneration: Diffusion MRI and cerebrospinal fluid aquaporin‐4 for the assessment of glymphatic system in Alzheimer's disease and other dementias 199
Cerebrospinal Fluid Biomarkers in Progranulin Mutations Carriers 197
Effect of fingolimod treatment on circulating miR-15b, miR23a and miR-223 levels in patients with multiple sclerosis 195
Differential miRNA expression in neural-enriched extracellular vesicles as potential biomarker for frontotemporal dementia and bipolar disorder 193
A case of bipolar disorder developing into atypical parkinsonism and presenting with frontotemporal asymmetrical brain degeneration : A TREDEM Registry Case Report 192
Role of hnRNP-A1 and miR-590-3p in neuronal death : genetics and expression analysis in patients with Alzheimer’s disease and Frontotemporal Lobar Degeneration 190
Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies 190
MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers 189
Transmembrane protein 106B gene (TMEM106B) variability and influence on progranulin plasma levels in patients with Alzheimer's Disease 188
Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation 188
Niemann-Pick Type C 1 (NPC1) and NPC2 gene variability in demented patients with evidence of brain amyloid deposition 188
Expression profile of miRNAs involved in CD4+ lymphocyte activation and differentiation in patients with multiple sclerosis 187
GRN Asp22fs mutation is associated with highly variable age at onset, clinical phenotype and brain atrophy 185
Inflammatory expression profile in peripheral blood mononuclear cells from patients with Nasu-Hakola Disease 185
LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients 184
CHMP5 and BAG1 are protective factors for sporadic frontotemporal lobar degeneration 183
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 182
Distribution of the C9orf72 hexanucleotide repeat expansion in healthy subjects: a multicenter study promoted by the Italian IRCCS network of neuroscience and neurorehabilitation 180
Genetics and expression analysis of the specificity protein 4 gene (SP4) in patients with Alzheimer's disease and frontotemporal lobar degeneration 178
miRNA Expression Is Increased in Serum from Patients with Semantic Variant Primary Progressive Aphasia 173
Expression and genetic analysis of microRNAs involved in multiple sclerosis 173
Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study 169
Expression of the transcription factor Sp1 and its regulatory hsa-miR-29b in peripheral blood mononuclear cells from patients with alzheimer's disease 168
Innate immune system and inflammation in Alzheimer's disease : from pathogenesis to treatment 167
Phenotypic heterogeneity of the progranulin gene Asp22fs mutation in a large Italian kindred 166
Expression and genetic analysis of miRNAs involved in CD4+cell activation in patients with multiple sclerosis 165
C9ORF72 hexanucleotide repeat expansion as a rare cause of bipolar disorder 164
Oligodendrocyte lineage transcription factor-2 role in Alzheimer’s disease : association and expression analysis 163
Role of OLR1 and its regulating has-miR369-3p in Alzheimer’s disease: genetic and expression analysis 163
Profiling of specific gene expression pathways in peripheral cells from prodromal Alzheimer's disease patients 161
The Role of Glymphatic System in Alzheimer’s and Parkinson’s Disease Pathogenesis 160
OLR1 and its regulatory miR-369-3p : genetics and expression analysis 160
A genome-wide screening and SNPs-to-genes approach to identify novel genetic risk factors associated with frontotemporal dementia 159
Analysis of C9orf72 Intermediate Alleles in a Retrospective Cohort of Neurological Patients: Risk Factors for Alzheimer's Disease? 159
TMEM106B genetic variability in patients with Alzheimer’s disease 158
Oligodendrocyte Lineage Transcription Factor 2 role in Alzheimer’s disease : association and expression analysis 157
C9ORF72 hexanucleotide repeat expansion frequency in patients with Paget's disease of bone 156
Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic Syndrome 156
Inflammatory plasma profile in genetic symptomatic and presymptomatic Frontotemporal Dementia − A GENFI study 152
GRN Asp22fs mutation is associated with heterogeneous neurodegenerative clinical phenotypes 150
The C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia 143
Genetics and expression analysis of the transcription factor Sp4 in patients with Alzheimer’s disease and frontotemporal lobar degeneration 141
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease 140
Letter to the editor on a paper by Kaivola et al. (2020): carriership of two copies of C9orf72 hexanucleotide repeat intermediate-length alleles is not associated with amyotrophic lateral sclerosis or frontotemporal dementia 136
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia 136
Non Fluent Variant of Primary Progressive Aphasia Due to the Novel GRN g.9543delA(IVS3-2delA) Mutation 134
Decreased circulating miRNAs in patients with multiple sclerosis 132
A Case with Early Onset Alzheimer's Disease, Frontotemporal Hypometabolism, ApoE Genotype ϵ 4/ ϵ 4 and C9ORF72 Intermediate Expansion : A Treviso Dementia (TREDEM) Registry Case Report 129
Cerebrovascular Reactivity at Rest and Its Association With Cognitive Function in People With Genetic Frontotemporal Dementia 125
Totale 21.168
Salva come PNG Salva come JPEG
Categoria #
all - tutte 66.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.960
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.141 0 53 50 89 103 65 114 77 147 117 111 215
2022/20231.693 230 169 139 169 171 334 45 122 164 36 98 16
2023/20241.266 29 85 89 77 308 78 62 105 54 105 132 142
2024/20253.493 93 334 116 332 263 121 193 307 207 390 329 808
2025/20267.866 744 466 606 589 647 451 1.084 332 769 504 1.018 656
2026/20271.059 527 532 0 0 0 0 0 0 0 0 0 0
Totale 22.793